Order Article Reprints

Miró L, López J, Guerrero PE, Martínez-Bosch N, Manero-Rupérez N, Moreno M, Ortiz MR, Llop E, Navarro P, Peracaula R. Sialyltransferase Inhibitor Ac₅3F_axNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice. Cancers. 2022; 14(24):6133. https://doi.org/10.3390/cancers14246133

Miró, Laura, Júlia López, Pedro E. Guerrero, Neus Martínez-Bosch, Noemí Manero-Rupérez, Mireia Moreno, M. Rosa Ortiz, Esther Llop, Pilar Navarro, and Rosa Peracaula. 2022. "Sialyltransferase Inhibitor Ac₅3F_axNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice" Cancers 14, no. 24: 6133. https://doi.org/10.3390/cancers14246133

Miró, L., López, J., Guerrero, P. E., Martínez-Bosch, N., Manero-Rupérez, N., Moreno, M., Ortiz, M. R., Llop, E., Navarro, P., & Peracaula, R. (2022). Sialyltransferase Inhibitor Ac₅3F_axNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice. Cancers, 14(24), 6133. https://doi.org/10.3390/cancers14246133